|
|
Substance Name: Dapagliflozin [USAN:INN]
RN: 461432-26-8
UNII: 1ULL0QJ8UC
InChIKey: JVHXJTBJCFBINQ-ADAARDCZSA-N
Note
- Dapaglifozin is the (2S,3R,4R,5S,6R)-isomer; an SGLT2 inhibitor.
Molecular Formula
- C21-H25-Cl-O6
Molecular Weight
- 408.8755
Classification Codes
- Antiviral (COVID-19)
- Hypoglycemic Agents
- Sodium-Glucose Transporter 2 Inhibitors
- Treatment of Type 1 or Type 2 Diabetes, or any Condition Causing Hyperglycemia
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- 2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
- Dapagliflozin [USAN:INN]
Synonyms
- (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- BMS 512148
- BMS-512148
- Dapagliflozin
- Farxiga
- Forxiga
- UNII-1ULL0QJ8UC
Systematic Name
- D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-
Registry Numbers
CAS Registry Number
- 461432-26-8
FDA UNII
- 1ULL0QJ8UC
System Generated Number
- 0461432268